Peripherally Inserted Central Catheter Market Report: Trends, Forecast and Competitive Analysis to 2030

Peripherally Inserted Central Catheter Trends and Forecast

The future of the global peripherally inserted central catheter market looks promising with opportunities in the hospital, cancer research institute, long term care center, independent infusion center, ambulatory surgical center, and home care setting markets. The global peripherally inserted central catheter market is expected to reach an estimated $1.1 billion by 2030 with a CAGR of 3.5% from 2024 to 2030. The major drivers for this market are increasing demand for quick and convenient drug delivery systems, growing number of hospitalizations in the worldwide, and rising prevalence of infectious disease.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Peripherally Inserted Central Catheter by Segment

The study includes a forecast for the global peripherally inserted central catheter by product type, lumen, application, end use, and region.

Peripherally Inserted Central Catheter Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Conventional PICC
• Power Injected PICC
• Neonatal PICC

Peripherally Inserted Central Catheter Market by Lumen [Shipment Analysis by Value from 2018 to 2030]:

• Single Lumen
• Double Lumen
• Multiple Lumen

Peripherally Inserted Central Catheter Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Chemotherapy
• Long-term IV Infusion
• Parenteral Nutrition
• Blood Transfusion
• Difficult Intravenous Access
• Others

Peripherally Inserted Central Catheter Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Cancer Research Institutes
• Long Term Care Centers
• Independent Infusion Centers
• Ambulatory Surgical Center
• Home Care Settings
• Others

Peripherally Inserted Central Catheter Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Peripherally Inserted Central Catheter Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies peripherally inserted central catheter companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the peripherally inserted central catheter companies profiled in this report include-

• Vygon
• Becton, Dickinson and Company
• Cardinal Health
• ICU Medical
• Kimal
• Poly Medicure
• Teleflex
• AngioDynamics
• B. Braun Medical
• Haolang Technology

Peripherally Inserted Central Catheter Market Insights

Lucintel forecasts that long-term IV infusion is expected to witness the highest growth over the forecast period.

Within this market, hospital will remain the largest segment over the forecast period.

North America will remain the largest region over the forecast period.

Features of the Global Peripherally Inserted Central Catheter Market

Market Size Estimates: Peripherally inserted central catheter market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Peripherally inserted central catheter market size by various segments, such as by product type, lumen, application, end use, and region in terms of value ($B).

Regional Analysis: Peripherally inserted central catheter market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, lumens, applications, end uses, and regions for the peripherally inserted central catheter market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the peripherally inserted central catheter market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the peripherally inserted central catheter market size?

Answer: The global peripherally inserted central catheter market is expected to reach an estimated $1.1 billion by 2030.

Q2. What is the growth forecast for peripherally inserted central catheter market?

Answer: The global peripherally inserted central catheter market is expected to grow with a CAGR of 3.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the peripherally inserted central catheter market?

Answer: The major drivers for this market are increasing demand for quick and convenient drug delivery systems, growing number of hospitalizations in the worldwide, and rising prevalence of infectious disease.

Q4. What are the major segments for peripherally inserted central catheter market?

Answer: The future of the peripherally inserted central catheter market looks promising with opportunities in the hospital, cancer research institute, long term care center, independent infusion center, ambulatory surgical center, and home care setting markets.

Q5. Who are the key peripherally inserted central catheter market companies?

Answer: Some of the key peripherally inserted central catheter companies are as follows:

• Vygon
• Becton, Dickinson and Company
• Cardinal Health
• ICU Medical
• Kimal
• Poly Medicure
• Teleflex
• AngioDynamics
• B. Braun Medical
• Haolang Technology

Q6. Which peripherally inserted central catheter market segment will be the largest in future?

Answer: Lucintel forecasts that long-term IV infusion is expected to witness the highest growth over the forecast period.

Q7. In peripherally inserted central catheter market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the peripherally inserted central catheter market by product type (conventional PICC, power injected PICC, and neonatal PICC), lumen (single lumen, double lumen, and multiple lumen), application (chemotherapy, long-term IV infusion, parenteral nutrition, blood transfusion, difficult intravenous access, and others), end use (hospitals, cancer research institutes, long term care centers, independent infusion centers, ambulatory surgical center, home care settings, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?